Guanjie Qin

MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2

Wei Jiang, Huiyun Yang, Guanjie Qin, 2022, Cell Death & Disease.

Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma

Wei Jiang, Huiyun Yang, Yunyan Mo, 2022, Strahlentherapie und Onkologie.

Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.

Ying Sun, Y. Mao, Jun Ma, 2022, The Lancet. Oncology.

Methylation‐associated silencing of miR‐9‐1 promotes nasopharyngeal carcinoma progression and glycolysis via HK2

Wei Jiang, Hua-ying Tang, Guanjie Qin, 2021, Cancer science.

Feasibility and efficiency of double-agent versus single-agent concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.

Wei Jiang, Bin Zhang, Yunyan Mo, 2020, Oral oncology.

Hypofractionated Radiotherapy compared with Conventionally Fractionated Radiotherapy to treat Initial Distant Metastases in Nasopharyngeal Carcinoma: A Multicenter, prospective, randomized, Phase II Trial.

Wei Jiang, Bin Zhang, Yunyan Mo, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma: A Randomized Clinical Trial.

Yunyan Mo, Yuan Xie, Yixin Su, 2024, JAMA oncology.

An individualized immune prognostic signature in nasopharyngeal carcinoma.

Yunyan Mo, Shufang Liao, Yuan Xie, 2024, Oral oncology.